{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T01:09:23Z","timestamp":1696381763236},"reference-count":31,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":3836,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,3]]},"DOI":"10.1197\/j.aem.2004.09.020","type":"journal-article","created":{"date-parts":[[2005,3,1]],"date-time":"2005-03-01T21:33:11Z","timestamp":1109712791000},"page":"185-189","source":"Crossref","is-referenced-by-count":6,"title":["Physostigmine Does Not Effect Arousal but Produces Toxicity in an Animal Model of Severe<i>\u03b3<\/i>-hydroxybutyrate Intoxication"],"prefix":"10.1111","volume":"12","author":[{"given":"Theodore C.","family":"Bania","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","reference":[{"key":"10.1197\/j.aem.2004.09.020-BIB1","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1081\/CLT-120015839","article-title":"Physostigmine as a treatment for gamma-hydroxybutyrate toxicity: a review.","volume":"40","author":"Traub","year":"2002","journal-title":"J Toxicol Clin Toxicol."},{"key":"10.1197\/j.aem.2004.09.020-BIB2","first-page":"4","article-title":"Food and Drug Administration. Updates: injuries, death linked to GHB abuse.","volume":"31","year":"1997","unstructured":"Food and Drug Administration. Updates: injuries, death linked to GHB abuse. FDA Consumer. 1997; 31:4.","journal-title":"FDA Consumer."},{"key":"10.1197\/j.aem.2004.09.020-BIB3","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3109\/15563658308990429","article-title":"Physostigmine versus naloxone in heroin overdose.","volume":"21","author":"Rupreht","year":"1983","journal-title":"J Toxicol Clin Toxicol."},{"key":"10.1197\/j.aem.2004.09.020-BIB4","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0022-3476(75)80717-7","article-title":"The use of physostigmine as an antidote in accidental diazepam intoxication.","volume":"86","author":"Di Liberti","year":"1975","journal-title":"J Pediatr."},{"key":"10.1197\/j.aem.2004.09.020-BIB5","volume-title":"A retrospective review of physostigmine in olanzapine overdose","author":"Ferraro","year":"2002"},{"key":"10.1197\/j.aem.2004.09.020-BIB6","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3171\/jns.1989.71.2.0273","article-title":"Physostigmine in the treatment of intrathecal baclofen overdose. Report of three cases.","volume":"71","author":"Muller-Schwefe","year":"1989","journal-title":"J Neurosurg."},{"key":"10.1197\/j.aem.2004.09.020-BIB7","doi-asserted-by":"crossref","first-page":"401","DOI":"10.4065\/75.4.401","article-title":"Physostigmine in the treatment of gamma-hydroxybutyric acid overdose.","volume":"75","author":"Yates","year":"2000","journal-title":"Mayo Clin Proc."},{"key":"10.1197\/j.aem.2004.09.020-BIB8","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1067\/mem.2001.111642","article-title":"Gamma-hydroxybutyrate overdose and physostigmine: teaching new tricks to an old drug?","volume":"37","author":"Caldicott","year":"2001","journal-title":"Ann Emerg Med."},{"key":"10.1197\/j.aem.2004.09.020-BIB9","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1067\/mem.2001.117502","article-title":"Use of physostigmine in the management of gamma-hydroxybutyrate overdose [letter].","volume":"38","author":"Boyer","year":"2001","journal-title":"Ann Emerg Med."},{"key":"10.1197\/j.aem.2004.09.020-BIB10","first-page":"439","article-title":"An investigation of flumazenil to antagonize gamma hydroxybutyrate intoxication in a murine model [abstract].","volume":"4","author":"Satz","year":"1997","journal-title":"Acad Emerg Med."},{"key":"10.1197\/j.aem.2004.09.020-BIB11","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1197\/j.aem.2004.02.272","article-title":"Naloxone does not reverse the sedative effect of gamma-butyrolactone in a rat model of severe intoxication [abstract].","volume":"11","author":"Chu","year":"2004","journal-title":"Acad Emerg Med."},{"key":"10.1197\/j.aem.2004.09.020-BIB12","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/0006-2952(66)90045-1","article-title":"Gammabutrylactone and gamma-hydroxybutyrate. Distribution and metabolism.","volume":"15","author":"Roth","year":"1966","journal-title":"Biochem Pharmacol."},{"key":"10.1197\/j.aem.2004.09.020-BIB13","doi-asserted-by":"crossref","first-page":"484b","DOI":"10.1197\/aemj.9.5.484-b","article-title":"Tolerance to gamma-hydroxybutyrate (GHB) in the rat: pharmacokinetic and pharmacodynamic aspects [abstract].","volume":"9","author":"Van Sassenbroeck","year":"2002","journal-title":"Acad Emerg Med."},{"key":"10.1197\/j.aem.2004.09.020-BIB14","first-page":"1","article-title":"Physostigmine, sodium bicarbonate, or hypertonic saline to treat diphenhydramine toxicity.","volume":"44","author":"Holger","year":"2002","journal-title":"Vet Hum Toxicol."},{"key":"10.1197\/j.aem.2004.09.020-BIB15","volume-title":"The UFAW Handbook on the Care & Management of Laboratory Animals, ed 6","year":"1986","unstructured":"PooleTB (ed). The UFAW Handbook on the Care & Management of Laboratory Animals, ed 6. Harlow, England: Longman Scientific & Technical, 1986."},{"key":"10.1197\/j.aem.2004.09.020-BIB16","first-page":"168","article-title":"Physostigmine treatment in various drug-induced intoxications.","volume":"14","author":"Nilson","year":"1982","journal-title":"Ann Clin Res."},{"key":"10.1197\/j.aem.2004.09.020-BIB17","first-page":"544","volume-title":"Goldfrank's Toxicological Emergencies, ed 6","author":"Howland","year":"2002"},{"issue":"2","key":"10.1197\/j.aem.2004.09.020-BIB18","first-page":"1","article-title":"Psychiatric emergencies.","volume":"18","author":"Olmeda","year":"2000","journal-title":"Emerg Med Clin North Am."},{"key":"10.1197\/j.aem.2004.09.020-BIB19","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0306-9877(96)90157-7","article-title":"What is the role of the gamma-hydroxybutyrate receptor?","volume":"47","author":"Cash","year":"1996","journal-title":"Med Hypotheses."},{"issue":"3","key":"10.1197\/j.aem.2004.09.020-BIB20","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/BF02191883","article-title":"Clinical efficacy of gamma-hydroxybutric acid treatment of opiate withdrawal.","volume":"244","author":"Gallimberti","year":"1994","journal-title":"Eur Arch Psychiatry Clin Neurosci."},{"key":"10.1197\/j.aem.2004.09.020-BIB21","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/BF00509765","article-title":"Effect of anesthetic doses of gamma-hydroxybutyrate on the acetylcholine content of rat brain.","volume":"295","author":"Sethy","year":"1976","journal-title":"Naunyn Schmiedebergs Arch Pharmacol."},{"key":"10.1197\/j.aem.2004.09.020-BIB22","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/S0196-0644(98)70230-6","article-title":"Clinical course of gamma-hydroxybutyrate overdose.","volume":"31","author":"Chin","year":"1998","journal-title":"Ann Emerg Med."},{"key":"10.1197\/j.aem.2004.09.020-BIB23","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/S0196-0644(80)80232-0","article-title":"Asystole complicating physostigmine treatment of tricyclic antidepressant overdose.","volume":"9","author":"Pentel","year":"1980","journal-title":"Ann Emerg Med."},{"key":"10.1197\/j.aem.2004.09.020-BIB24","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1001\/jama.1975.03240210021012","article-title":"Physostigmine salicylate in the treatment of tricyclic antidepressant overdosage.","volume":"231","author":"Newton","year":"1975","journal-title":"JAMA."},{"key":"10.1197\/j.aem.2004.09.020-BIB25","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1046\/j.1360-0443.2003.00265.x","article-title":"The prevalence and correlates of gamma-hydroxybutyrate (GHB) overdose among Australian users.","volume":"98","author":"Degenhardt","year":"2003","journal-title":"Addiction."},{"key":"10.1197\/j.aem.2004.09.020-BIB26","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1212\/WNL.30.8.832","article-title":"Naloxone overcomes the dopaminergic, EEG, and behavioral effects of gamma-hydroxybutyrate.","volume":"30","author":"Snead","year":"1980","journal-title":"Neurology."},{"key":"10.1197\/j.aem.2004.09.020-BIB27","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0304-3940(96)12786-5","article-title":"Lack of effect of gamma-hydroxybutyrate on mu, sigma and kappa opioid receptor binding.","volume":"212","year":"1996","unstructured":"Lack of effect of gamma-hydroxybutyrate on mu, sigma and kappa opioid receptor binding. Neurosci Lett. 1996; 212:5-8.","journal-title":"Neurosci Lett."},{"key":"10.1197\/j.aem.2004.09.020-BIB28","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1159\/000116684","article-title":"Risk and benefits of therapy with flumazenil (Anexate) in mixed drug intoxications.","volume":"31","author":"Geller","year":"1991","journal-title":"Eur Neurol."},{"key":"10.1197\/j.aem.2004.09.020-BIB29","first-page":"292","article-title":"Flumazenil and seizures: analysis of 43 cases.","volume":"14","author":"Spivey","year":"1992","journal-title":"Clin Ther."},{"key":"10.1197\/j.aem.2004.09.020-BIB30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1081\/CLT-100100908","article-title":"The hemodynamic effects of cocaine during acute controlled hemorrhage in conscious rats.","volume":"38","author":"Bania","year":"2000","journal-title":"J Toxicol Clin Toxicol."},{"key":"10.1197\/j.aem.2004.09.020-BIB31","unstructured":"Wright, R , Wang, R. Poison antidotes. Emergency Medicine Reports. Available at: http:\/\/www.emronline.com\/. Accessed Sep 23, 2004."}],"container-title":["Academic Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1197%2Fj.aem.2004.09.020","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,31]],"date-time":"2019-01-31T11:20:53Z","timestamp":1548933653000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1197\/j.aem.2004.09.020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,3]]}},"URL":"https:\/\/doi.org\/10.1197\/j.aem.2004.09.020","relation":{},"ISSN":["1069-6563","1553-2712"],"issn-type":[{"value":"1069-6563","type":"print"},{"value":"1553-2712","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,3]]}}}